What are your thoughts on the quarter and guidance for Well Health? Is it still on your small/mid cap favorite list? If yes where would you list in your top 5 choices? WELL EPS was 5c, off estimates of 5.5c; revenue of $251.7M beat estimates of $247M. EBITDA of $32.7M beat estimates by 2%. Gross margin was 44.6%. Revenue guidance was raised to $985M+, from $970M+. EBITDA range was also raised. Its $1B run rate was achieved ahead of plan. Revenue rose 27%; EBITDA rose 16%. Patient visits increased 41%. It was a solid quarter/outlook and the stock finally made a move today.
We would consider: TVK, HPS.A, WELL, TCS, VHI as favourites in order.
and as a result..........
Growth Model Portfolio
Increase Well Health Technologies (WELL) Position to a 4.0% Weighting
Trade Rationale - WELL reported earnings today, with revenue guidance being raised and its EBITDA range also raised. WELL’s $1 billion run rate was achieved ahead of plan, and overall it was a strong quarter/outlook which caused the stock to make a move. We like the fundamentals of WELL, and with rates declining, we feel that it can both improve its margins and make potential acquisitions with a lower cost of capital.